What's breaking now, across thousands of outlets.
(MedPage Today) -- Adding the BCL2 inhibitor venetoclax (Venclexta) to chemoimmunotherapy led to worse outcomes and excess mortality in patients with newly diagnosed double-hit lymphoma, phase II results from a randomized trial showed. Median...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The death of a Canberra woman is the first in the ACT to be linked to a synthetic opioid which is estimated to be at least 100 times stronger than heroin, a coroner has found.
The CDC said it has received a rise in reports of human rabies exposure cases this summer, prompting an alert to healthcare providers.
(MedPage Today) -- New multiple sclerosis (MS) patients treated with B-cell-depleting drugs or high-efficacy therapies had lower relapse rates and fewer brain lesions than those treated with oral…
UCLA researchers have identified a pathway in liver cells that may explain how statins could help prevent or slow the development of liver cancer associated with fatty liver disease.
The top court orally said that the PIL was filed with an ulterior motive and lacked bonafide
In this GEN webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology. The post Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC…
